WHO issues warning about counterfeit diabetes drugs worldwide

WHO issues warning about counterfeit diabetes drugs worldwide


The World Health Organization (WHO) has said that since 2022, the distribution of counterfeit diabetes medicines has become a problem affecting all regions of the world.

The counterfeit medicines have been found in the UK, the US and Brazil since October 2023, health authorities said in a statement.

The drug in question is Ozempic, a medicine containing the active ingredient semaglutide, which is also approved in the EU as a treatment for type 2 diabetes.

Counterfeit drugs look identical to the real drugs.
This product also suppresses appetite and is increasingly being prescribed for weight loss.

But counterfeit medicines may not contain the correct amount of active ingredients, which could lead to diabetes patients losing control of their blood sugar levels, the WHO said.
It may also contain other active ingredients that pose health risks, he added.

The WHO called for increased vigilance among doctors, pharmacists, regulators and the public.

The WHO said people should only buy medicines on prescription from pharmacies and not online.

The company added that users should check that their insulin pens have the correct dosage markings, are properly labeled and have no spelling errors on the box.

Source: guardian.ng

Leave a Reply

Your email address will not be published. Required fields are marked *